Mindfulness Meditation and Cannabis Dependence : Therapy Effectiveness (MACBETH)

Central Hospital, Nancy, France

Status: Unknown

Conditions: Cannabis Dependence; Addiction; Cannabis Use

Treatments: Behavioral: Mindfulness based relapse prevention (MBRP); Behavioral: classic therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT03366909

2017-A01466-47

Details and patient eligibility

About

Cannabis use can lead to addiction in about 5 to 10 % of users in France. Currently, behavioral interventions are the most dependable but effectiveness is still reduced. Mindfulness meditation has demonstrated an effectiveness in several meta analysis (anxiety and depressive disorder) and seems to be relevant to reduce anxious and impulsive symptoms found in cannabis use disorders.

This study proposes to determinate the mindfulness effectiveness in reduction of cannabis use in regular consumer. The consumption decrease is estimated with a retrospective diary, TLFB (Timeline Follow Back) which collect cannabis use every week until the 12th. Urine (week 0/baseline, 2, 4, 6, 8, 10, 12) and hair (week 0/baseline, 10) analyses are regularly effected.

Patients included in control group get classic cares in an addictology center in CHRU of Nancy. Patients included in mindfulness group receive one session a week during eight weeks (MBRP protocol : Mindfulness -Based Relapse Prevention). The study process goes on for 12 weeks.

An ancillary study measures the impact of cannabis decreases on retinal electrophysiological and architectural markers, usually disturbed by cannabis uses.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged from 18 to 55
• cannabis use: more than 7 joint a week or diagnostic of abuse/dependence at MINI (mini international neuropsychiatric interview)
• Recent use authenticated in urine
• patient voluntary to stop cannabis use
• patient with social security
• written consent for study

Exclusion criteria

• alcohol dependence (AUDIT: alcohol use disorders test)
• other psychoactive substance abuse or dependence (DSM 4)
• Progressive psychiatric disorder (MINII) excepted anxious disorder)
• Current neurologic disorder
• Patient deficiency with difficulty or impossibility to understand informations
• protection of vulnerable adults as guardianship or judicial protection
• pregnant or breastfeeding woman
• vital emergency
• no social security
• participation in another interventional study
• current retinal disorder (ancillary study)
• chronic glaucoma (ancillary study)
• opthalmologic disease decreasing visual acuity (ancillary study)
• current ocular infection

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

MBRP group

Experimental group

Description:

20 patients 2 groups of 10 patients

Treatment:

Behavioral: Mindfulness based relapse prevention (MBRP)

classic care in addictology center

Active Comparator group

Description:

20 patients

Treatment:

Behavioral: classic therapy